Previous ZIKV infection in humans and experimental animals or immunization generate neutralizing antibodies, especially against epitopes on the envelope protein dimer or in domain III (EDIII), which are efficient in preventing ZIKV infection and disease27–31. This evidence concerns the gene ERVW-1 and Zika virus infectious disease.